Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ioannidis JPA, Trikalinos TA
doi: 10.1007/s12672-019-0357-x 71 HaSJinBClemmensenBParkPMahboobSGladwillVet al
From a safety perspective, more robust data assessing the effect of resmetirom in patients living with thyroid disease, hypothyroidism, hyperthyroidism, thyroid nodules will be particularly relevant
Additionally, small sample sizes, short durations and selective participant recruitment limit the identification of rare or long-term adverse events
Redox Biol 2(2):535562
The REWIND trial's cognitive substudy with dulaglutide and smaller trials of liraglutide in Alzheimer's disease have shown modest or inconsistent effects
US$ 23.62
US$ 22.48
US$ 26.23
US$ 23.32
